Joseph Meister and the laboratory vaccine

On 6 July 1885, nine-year-old Joseph Meister from Alsace began an experimental course of rabies vaccination in Paris after suffering multiple bites from a dog reported to be rabid. The treatment became the landmark human application associated with Louis Pasteur. Pasteur was not a physician; the doctor Jacques-Joseph Grancher administered the injections. Meister did not subsequently develop rabies.

The intervention emerged from laboratory research involving Pasteur, Émile Roux and other collaborators. Experiments with infected animals had produced preparations from rabbit spinal cords whose infectious activity diminished during drying. Meister received thirteen injections over approximately ten days, using progressively fresher preparations. The reasoning was that protection could develop before disease followed the original exposure.

This was a significant extension of vaccination: laboratory manipulation of infectious material supported an intervention after a dangerous bite. Yet the researchers could not directly observe the rabies virus with the microscopes available to them. Their work depended on animal experiments and observed outcomes rather than modern virological identification. Institut Pasteur’s historical account describes this experimental background.

What does “first” mean?

The conventional title needs qualification. Historical examination of Pasteur’s laboratory notebooks identifies earlier human administrations in May and June 1885. These included an interrupted course for an adult and an injection given to a girl who died the following day. Their circumstances and outcomes differed from Meister’s celebrated case. Meister therefore represents the landmark successful course conventionally commemorated as the first human rabies vaccination, rather than an uncontested first administration to any person. These earlier episodes are discussed in Louis Pasteur: Between Myth and Reality.

The distinction changes how the event should be interpreted. A familiar story of a single decisive experiment compresses a less orderly transition from animal research to human intervention. The notebook evidence also raises questions about how much experimental support existed when treatment began. Historical assessment must distinguish the researchers’ hopes, the evidence available at the time and the confidence later attached to the outcome. Meister’s survival was consequential, but one person’s survival alone could not establish the effectiveness or safety of a method for every exposed patient.

From an experimental intervention to an institution

The public importance of the episode extended beyond Meister. Reports of successful treatment attracted people with animal bites to Paris and created pressure for a dedicated service. In March 1886, Pasteur presented results from a larger series to the French Academy of Sciences. A committee then supported an international appeal for a vaccination center.

The resulting Institut Pasteur received official charitable status in 1887 and opened on 14 November 1888. Its purposes combined rabies treatment, infectious-disease research and teaching. Donations linked the laboratory enterprise to an international public, while the new institution gave the work a more durable organizational basis.

This institutional sequence suggests that the legacy of 1885 cannot be reduced to an injection or a celebrated scientist. It also involved establishing facilities, financing continuing research and organizing the transfer of laboratory knowledge into clinical practice. The institute’s account of its construction and foundation documents those developments.

Prevention after exposure, not a cure for established disease

Calling Meister’s treatment a cure can obscure its significance. Exposure to a potentially infected animal and symptomatic rabies are different conditions. Modern understanding identifies rabies as a viral infection affecting the central nervous system. Prevention after exposure aims to stop disease developing; it is not equivalent to reversing established neurological illness, which is almost invariably fatal. The World Health Organization’s rabies overview explains this distinction.

Meister’s case belongs within the history of vaccination, but the experimental preparations described here are historical practices, not instructions for present care. Its continuing significance lies in the possibility of preventing disease after exposure, alongside the persistent need to evaluate evidence carefully. Effective prevention also depends on access: the existence of vaccines does not by itself ensure that people exposed to rabies can obtain them. This makes the event relevant both to the history of laboratory medicine and to the history of public-health provision.

Sources and further reading